Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
CINCINNATI, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) ('Onconetix' or the 'Company'), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology, today announced that the Company's stockholders have approved a proposal to effect a reverse split, which was voted on at the Company's 2025 special meeting of stockholders (the 'Special Meeting') held on May 30, 2025, and that its Board of Directors (the 'Board of Directors' or 'Board') approved a 1-for-85 reverse stock split of its outstanding shares of common stock, to be effective as of 12:01 a.m. Eastern Time on June 13, 2025.
Results of the Special Meeting
At the Special Meeting, Onconetix's stockholders approved the following proposals:
an amendment to the Onconetix, Inc. Amended and Restated Certificate of Incorporation to effect a reverse stock split of all of the outstanding shares of the Company's common stock, par value $0.00001 per share, at a ratio in the range of 1-for-10 to 1-for-150, at any time prior to the one-year anniversary date of the Special Meeting, with such ratio to be determined by the Board without further approval or authorization of the stockholders; and
the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Reverse Stock Split Proposal. (the 'Adjournment Proposal').
Final voting results from the Special Meeting were reported in a Current Report on Form 8-K filed with the Securities and Exchange Commission (the 'SEC') on June 5, 2025.
In conjunction with stockholder approval of the reverse stock split, the Company's Board of Directors determined to fix a split ratio of 1-for-85 shares. The Company's common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on June 13, 2025. Following the reverse stock split, the Company's common stock will continue to trade on The Nasdaq Capital Market under the symbol 'ONCO' under the new CUSIP number 68237Q203. The reverse stock split is intended to enable the Company to regain compliance with the minimum bid price requirement of $1.00 per share of common stock for continued listing on The Nasdaq Capital Market.
At the effective time of the reverse split, every 85 issued and outstanding shares of the Company's common stock will be converted automatically into one share of the Company's common stock without any change in the par value per share. No fractional shares will be issued in connection with the reverse stock split, and fractional shares resulting from the reverse stock split will be canceled with the holders thereof receiving cash compensation. The amount of compensation will be determined by multiplying the fractional share by the closing price per share of the Company's common stock on The Nasdaq Capital Market at the close of business on the trading day prior to the effective date of the reserve stock split, or June 12, 2025. The reverse split will have no effect on the number of authorized shares of the Company's common stock, and the ownership percentage of each stockholder will remain unchanged other than as a result of fractional shares. The reverse stock split will additionally apply to the Company's common stock issuable upon exercise or conversion of the Company's equity awards, convertible preferred stock and warrants, as well as the applicable exercise price.
The reverse stock split will reduce the number of outstanding shares of the Company's common stock from approximately 44.4 million to approximately 521,863.
About Onconetix, Inc.
Onconetix, Inc. is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. The Company owns Proclarix, an in vitro diagnostic test for prostate cancer originally developed by Proteomedix and approved for sale in the European Union under the In Vitro Diagnostic Regulation. The Company also owns ENTADFI, an FDA-approved, once-daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia, a disorder of the prostate. For more information, visit www.onconetix.com.
Forward-Looking Statements
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as 'anticipate,' 'believe,' 'forecast,' 'estimate,' 'expect,' and 'intend,' among others. These forward-looking statements (including, without limitation, statements regarding the timing and effectiveness of the anticipated reverse split and compliance with applicable Nasdaq continued listing requirements) are based on Onconetix's current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, market and other conditions; whether the Company will be able to regain and maintain compliance with Nasdaq's applicable listing criteria and the effect of a delisting from Nasdaq on the market for the Company's securities; whether a definitive agreement for the proposed transaction with Ocuvex Therapeutics, Inc. ('Ocuvex') and any related financing will be entered into; whether such transactions, or any other contemplated transaction, may be completed with different terms, in an untimely manner, or not at all; whether the Company will be able to realize the benefits of a proposed transaction with Ocuvex; Onconetix's ability to integrate the assets and commercial operations contemplated to be acquired from Ocuvex into the Company's business; risks related to Onconetix's ability to commercialize or monetize Proclarix and integrate the assets and commercial operations; risks related to the Company's present need for capital to commercially launch Proclarix and have adequate working capital; risks related to Onconetix's ability to attract, hire and retain skilled personnel necessary to commercialize and operate the Company's commercial products; the failure to obtain and maintain the necessary regulatory approvals to market and commercialize Onconetix's products; risks related to the Company's ability to obtain and maintain intellectual property protection for its current products; and the Company's reliance on third parties, including manufacturers and logistics companies. As with any commercial-stage pharmaceutical product or any product candidate under clinical development, there are significant risks in the development, regulatory approval and commercialization of biotechnology products. Onconetix does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in Onconetix's Annual Report on Form 10-K, filed with the SEC on June 2, 2025 and periodic reports filed with the SEC on or after the date thereof. All of Onconetix's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date thereof.
For more information:
Onconetix, Inc.
201 E. Fifth Street, Suite 1900
Cincinnati, OH 45202
Phone: (513) 620-4101
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
39 minutes ago
- Time Business News
The Scent of Queues: How Master Bun Pastry Is Winning Over London with Chinese-Inspired Creative Baking
Chinese Pastries Land in London, Spark a 'Baking Craze' In a city renowned for its culinary diversity, a new wave of flavor is redefining what dessert means to Londoners. Master Bun Pastry — a beloved bakery brand with over 300 stores across China — has quietly ignited a unique baking phenomenon with the launch of its very first UK store in London's Chinatown. Combining traditional Chinese craftsmanship with a modern twist, the brand is bringing 'Eastern creative baking' to the heart of the British capital. The Eastern Sensation Changing British Taste Buds Unlike the typical structure and taste of Western desserts, Master Bun Pastry's products showcase the uniquely Chinese combination of crispy, chewy, savory, and sweet. Its signature bestseller, the 'Meat Floss Chiffon Bun,' blends seaweed, pork floss, and a fluffy chiffon base into an irresistible multi-layered treat. Other crowd-favorites include chocolate mochi puffs and chewy choux pastries with creamy centers and crispy shells — textures and flavors that many UK customers say they've never experienced before. From First Bite to Loyal Fans: Real Customer Stories 'Our first few weeks saw long lines forming outside the shop — many people were drawn in just by the crowd,' says the store manager. 'One young British customer tried a chocolate puff, bought five boxes on the spot, and came back ten minutes later for more.' Regular customers now include local residents of Asian heritage, and even Chinese students in France have brought boxes of meat floss buns back to Paris. Some long-time Malaysian and Hong Kong customers in the UK even call ahead to reserve their favorites — 'just in case they sell out.' Social Media Drives Organic Hype and Cultural Connection Master Bun Pastry's success is no accident. Riding the wave of Asian baking and Gen Z's cultural curiosity, the brand naturally fits into London's urban landscape — a city that celebrates diversity and innovation. Without traditional advertising, the brand has gained traction through organic user-generated content on platforms like TikTok, Instagram, and Xiaohongshu. Customers snap photos, post reviews, and film taste-test videos, forming a grassroots cultural bridge between Asian and local communities. Product Philosophy: Reinvention, Not Replication The founding team at Master Bun Pastry emphasizes that they never simply copy traditional Chinese pastries. Instead, they draw inspiration from Cantonese bakeries, Jiangnan sweets, Japanese wagashi, and blend it with British aesthetics and the evolving tastes of younger consumers. 'We see our work as a kind of cultural experiment — something delicious, playful, and memorable — to reimagine the role of Chinese pastries in the global dessert scene.' What's Next: Rooted in the UK, Aiming for the Mainstream Master Bun Pastry is already in the early stages of expansion. The brand plans to open 15 additional directly operated stores in major UK cities including Manchester, Glasgow, and Birmingham over the next three years. They are also exploring collaborations with local department stores, commercial developers, and lifestyle brands. More Than Just Desserts — A Cultural Resonance For lovers of Chinese pastries, dessert influencers, international students, and curious local foodies, Master Bun Pastry offers more than just a puff or mochi — it offers a modern expression of taste memory and cultural fusion. More than just a bakery from China, Master Bun Pastry is a cultural vessel — a warm, delicious experiment in flavor, identity, and belonging. TIME BUSINESS NEWS
Yahoo
40 minutes ago
- Yahoo
Michiganders are returning fewer bottles and cans. Why?
GRAND RAPIDS, Mich. (WOOD) — The value of a dime doesn't stretch as far as it did in 1976 when the state's bottle deposit law was initiated, but for many Michiganders, returning beverage containers to get their 10 cents back sure adds up. 'I don't want to throw my pennies and dimes away,' Grand Rapids resident Mildred Griffin said. 'The cost of living is so high right now. You would be a fool to throw away 10 cents.' For Griffin, returning bottles and cans is a way of life. She said it's like getting paid to recycle. She was surprised to learn that fewer people are turning in their bottles to get that dime back. Statewide return rates have fallen to their lowest point. In 2024, just over 70% of bottles and cans were returned. Workers at a number of local markets told News 8 they have seen fewer returns in recent years. At Kingma's Market in Grand Rapids, owner Alan Hartline said the redemption process adds complications to store owners. He said the process, from collecting to sorting, is in serious need of an update. 'It really taxes the supply chain and adds a lot of cost to it for businesses,' he said, 'I think there can be a better way to facilitate it. It should be earth friendly, but perhaps to do it without the cost and as many hoops as the current process today.' Sen. Sean McCann, D-Kalamazoo, also believes there's a need for change, including an expansion. 'Even though we've come off our highs, habits have changed, there's a real ability to still improve our system and make it get better,' he said. McCann reintroduced a bill to modify the bottle return law to include other containers, primarily plastic water bottles. 'I think it's terrible that we have over 2 billion plastic water bottles that don't necessarily get recycled and often get landfilled and are not eligible for the deposit,' he said. He's also pushing for bottles and cans to be returnable anywhere — not just at chains that carry the brands being returned. He said that is part of the reason the rates are dropping. 'Part of the bugaboo is a universal redemption,' he said. 'You buy something at one store (but) you can't take it back to the other store.' For McCann, the goal is to get the issue on the ballot and let the citizens decide. 'This is not something worth giving up on for me,' he said. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
43 minutes ago
- Yahoo
Avino Renews ATM Equity Program
VANCOUVER, BC / / June 13, 2025 / Avino Silver & Gold Mines Ltd. (TSX:ASM)(NYSE American:ASM)(FSE:GV6) ("Avino" or the "Company") announces that it has filed a prospectus supplement dated June 13, 2025 (the "Prospectus Supplement") to the Company's short form base shelf prospectus dated May 26, 2025 (the "Shelf Prospectus") with the securities commissions in each of the provinces and territories of Canada, with the exception of Québec, pursuant to which the Company may, at its discretion and from time to time, distribute common shares (the "Offered Shares") pursuant to a sales agreement dated June 13, 2023 (the "Sales Agreement") with Cantor Fitzgerald & Co. (the "Designated Agent"), H.C. Wainwright & Co. LLC, Roth Capital Partners, LLC, and A.G.P./Alliance Global Partners (collectively, with the Designated Agent, the "Agents"), as agents or as principals, for the distribution of the Offered Shares in the United States (the "ATMOffering") up to the aggregate sales amount of US$40 million (the "Maximum Amount"). A corresponding prospectus supplement has been filed with the United States Securities and Exchange Commission (the "SEC"). "We have re-established the ATM Offering after the previous offering expired in May 2025, and it will be used strategically as an additional source of financial flexibility if required, subject to regulatory requirements," said David Wolfin, Avino's President and CEO. The ATM Offering is being made in the United States under the terms of a registration statement on Form F-10, as amended and filed with, and declared effective on May 28, 2025, by the SEC in the United States, and the Shelf Prospectus and Prospectus Supplement filed in each province and territory of Canada, except Quebec; the Registration Statement, Shelf Prospectus and Prospectus Supplement being collectively, the "Prospectus"). Prospective investors should read the Prospectus (including the documents incorporated by reference therein) for more complete information about the Company and the ATM Offering, including the risks associated with investing in the Company and disclosure with respect to the proposed use of proceeds of the ATM Offering. The sales of the Offered Shares, if any, will be made directly on the NYSE American, or any other trading market for the Offered Shares in the United States or outside of Canada as otherwise agreed between the Agents and the Company, and will be deemed sales of Offered Shares under the Prospectus in transactions that are deemed to be "at-the-market distributions" as defined in National Instrument 44-102 - Shelf Distributions and Rule 415 of the Securities Act of 1933, as amended. The Offered Shares, if any, will be distributed at the market prices prevailing at the time of sale. As a result, prices may vary between purchasers and during the period of distribution. The ATM Offering will be effective until the earlier of (i) the date that the aggregate gross sales proceeds of the Offered Shares sold under the ATM Offering reaches the Maximum Amount, (ii) the receipt for the Shelf Prospectus ceasing to be effective in accordance with applicable securities laws, and (iii) the termination of the Sales Agreement in accordance with its terms. The Company has agreed to pay the Agents a cash commission up to 3.0% of the gross proceeds of the Offering. The Company is not obligated to make any sales of Offered Shares under the Distribution Agreement. There is no certainty that any Offered Shares will be offered or sold under the ATM Offering. Copies of the Shelf Prospectus, Prospectus Supplement and Registration Statement may be obtained on request without charge from: (i) the Company at Suite 900-570 Granville St., Vancouver, British Columbia, V6C 3P1, Canada, telephone (604) 682-3701; or (ii) Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59th Street, 6th floor, New York, New York 10022, by email at prospectus@ You may also obtain these documents free of charge under the Company's SEDAR+ profile at and on EDGAR at The Toronto Stock Exchange has conditionally approved the listing of the Offered Shares that may be sold under the ATM Offering. The Company intends to rely on the exemption in section 602.1 of the TSX Company Manual in respect of the ATM Offering as an "Eligible Interlisted Issuer" (as such term is defined in the TSX Company Manual). This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. About Avino:Avino is a silver producer from its wholly owned Avino Mine near Durango, Mexico. The Company's silver, gold and copper production remains unhedged. The Company intends to maintain long-term sustainable and profitable mining operations to reward shareholders and the community alike through our growth at the historic Avino Property and the strategic acquisition of the adjacent La Preciosa which was finalized in Q1 2022. Early in 2024, the pre-feasibility Study on the Oxide Tailings Project was completed. This study is a key milestone in our growth trajectory. As part of Avino's commitment to adopting sustainable practices, we have been operating a dry stack tailings facility for more than one year now with excellent results. We are committed to managing all business activities in a safe, environmentally responsible, and cost-effective manner, while contributing to the well-being of the communities in which we operate. We encourage you to connect with us on X (formerly Twitter) at @Avino_ASM and on LinkedIn at Avino Silver & Gold Mines. To view the Avino Mine VRIFY tour, please click here. This news release contains "forward-looking information" and "forward-looking statements" (together, the "forward-looking statements") within the meaning of applicable securities laws and the United States Private Securities Litigation Reform Act of 1995. This information and these statements, referred to herein as "forward-looking statements" are made as of the date of this document. Forward-looking statements relate to future events or future performance and reflect current estimates, predictions, expectations or beliefs regarding future events and include, but are not limited to, statements with respect to the distribution of Offered Shares, if any, under the ATM Offering and the benefits associated therewith and the use of net proceeds, if any, of the ATM Offering. expected operations at the Company's mineral properties. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives or future events or performance (often, but not always, using words or phrases such as "expects", "anticipates", "plans", "projects", "estimates", "envisages", "assumes", "intends", "strategy", "goals", "objectives" or variations thereof or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved, or the negative of any of these terms and similar expressions) are not statements of historical fact and may be forward-looking statements. These forward-looking statements are made as of the date of this news release. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the future circumstances, outcomes or results anticipated in or implied by such forward-looking statements will occur or that plans, intentions or expectations upon which the forward-looking statements are based will occur. While we have based these forward-looking statements on our expectations about future events at the date that such statements were prepared, the statements are not a guarantee that such future events will occur and are subject to risks, uncertainties, assumptions and other factors which could cause events or outcomes to differ materially from those expressed or implied by such forward-looking statements. Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release. For Further Information, Please Contact:Investor RelationsTel: 604-682-3701Email: IR@ SOURCE: Avino Silver & Gold Mines Ltd. View the original press release on ACCESS Newswire Sign in to access your portfolio
